首页|鲍曼不动杆菌抗生素耐药及同源性分析

鲍曼不动杆菌抗生素耐药及同源性分析

扫码查看
目的 了解我院住院患者及环境中鲍曼不动杆菌临床感染特点、耐药性及同源性,为临床有效治疗及感控预防提供参考.方法 收集我院部分科室及环境中2018年11月至2021年6月分离的824株鲍曼不动杆菌中重点科室怀疑存在交叉感染的47株鲍曼不动杆菌,采用Vitek-Ⅱ compact全自动微生物分析系统对菌株进行鉴定和药敏试验,采用多位点序列分型和基质辅助激光解析电离时间质谱(MALDI-TOF MS)对菌株进行同源性分析.结果 47株鲍曼不动杆菌对粘菌素表现为全部敏感,对替加环素、氨苄西林/舒巴坦、头孢哌酮/舒巴坦敏感率分别为89.5%、80.0%和56.6%,36株表现为3类以上抗生素耐药,MDRAB检出率为76.6%,多位点序列分型(MLST)得到8种序列型,以ST2型占优势(38株,占80.8%),其次为ST10型(2株,占4.3%)及ST132型(2株,占4.3%).分布特点以呼吸与危重症医学科、重症监护医学科和神经外科病房为主.结论 我院鲍曼不动杆菌耐药率较高,多个克隆株在院内广泛分布,部分科室存在较近的亲缘关系,提示院感防控需进一步加强.
An Analysis of Antibiotic Resistance and Homology of Acinetobacter Baumannii in Our Hospital
Objective To better understand the clinical infection characteristics,drug resistance and homology of A.baumannii in our inpatients and the environment,and to provide reference for effective clinical treatment and infection control and prevention.Methods A total of 824 strains of Acinetobacter baumannii isolated from selected departments and related environments of our hospital from November,2018 to June,2021 were collected,among which 47 strains of Acinetobacter baumannii suspected of cross infection in key departments were collected.We used Vitek-compact automatic microbial analysis system for strain identification and drug susceptibility test,and multi-site sequence typing and matrix assisted laser resolved ionization time mass spectrometry (MALDI-TOF MS)for homology analysis.Results 47 A.baumannii were susceptible to colistin,with 89.5%, 80.0% and 56.6% for cefoperazone and sulbactam.36 showed antibiotic resistance,76.6% for MDRAB,and 8 sequence types of ST2 (38,80.8%)were identified,followed by ST10 (2,4.3%)and ST132 (2,4.3%).The distribution characteristics were mainly in Respiratory and Critical Care Medicine,Intensive Care Medicine and Neurosurgery wards.Conclusion The resistance rate of Acinetobacter baumannii in our hospital is high.Several clonal strains are widely distributed in the hospital,and there is a close kinship relationship in some departments,which indicates that the prevention and control of hospital infection should be further strengthened.

Acinetobacter baumanniiEpidemiologyResistanceHomologyResistance geneGene recombination sequencing technology

耿荣华、崔兰卿、张佳、蔡珍、何宗辉、李鹏博、石莹莹

展开 >

航空总医院,北京 100020

北京大学第一医院临床药理研究所,北京 100034

鲍曼不动杆菌 流行病学 耐药性 同源性 耐药基因 基因重组测序技术

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(3)
  • 28